Development of targeted Covid-19 diagnostic tools in a new partnership
The La Jolla Institute of Immunology (LJI), a research organization dedicated to the study of the immune system, has signed a licensing agreement with Leinco Technologies, developer and manufacturer of recombinant proteins,…